Le retard diagnostique dans la maladie de Horton. Analyse du délai diagnostique à partir d'une étude rétrospective de 130 cas

Kelkel, E.; Sarrot-Reynauld, F.; Dussud, C.; Pasquier, Dominique; Massot, C

doi:10.1016/s0248-8663(05)82862-0

Cited by 4 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The majority of mean values had wide data ranges reported alongside them, with these often being skewed toward the higher value (Table 2 ). Five articles did not include all necessary data related to delay [ 25 , 27 , 29 , 35 , 38 ] and that of Hu et al [ 34 ] was excluded (Additional file 1 : Table S1), leaving 16 articles included in the meta-analysis [ 11 , 13 , 20 , 26 , 28 , 30 – 33 , 36 , 37 , 39 – 43 ].…”

Section: Resultsmentioning

confidence: 99%

Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis

Prior

Ranjbar

Belcher

et al. 2017

BMC Med

View full text Add to dashboard Cite

BackgroundGiant cell arteritis (GCA), if untreated, can lead to blindness and stroke. The study’s objectives were to (1) determine a new evidence-based benchmark of the extent of diagnostic delay for GCA and (2) examine the role of GCA-specific characteristics on diagnostic delay.MethodsMedical literature databases were searched from inception to November 2015. Articles were included if reporting a time-period of diagnostic delay between onset of GCA symptoms and diagnosis. Two reviewers assessed the quality of the final articles and extracted data from these. Random-effects meta-analysis was used to pool the mean time-period (95% confidence interval (CI)) between GCA symptom onset and diagnosis, and the delay observed for GCA-specific characteristics. Heterogeneity was assessed by I 2 and by 95% prediction interval (PI).ResultsOf 4128 articles initially identified, 16 provided data for meta-analysis. Mean diagnostic delay was 9.0 weeks (95% CI, 6.5 to 11.4) between symptom onset and GCA diagnosis (I 2 = 96.0%; P < 0.001; 95% PI, 0 to 19.2 weeks). Patients with a cranial presentation of GCA received a diagnosis after 7.7 (95% CI, 2.7 to 12.8) weeks (I 2 = 98.4%; P < 0.001; 95% PI, 0 to 27.6 weeks) and those with non-cranial GCA after 17.6 (95% CI, 9.7 to 25.5) weeks (I 2 = 96.6%; P < 0.001; 95% PI, 0 to 46.1 weeks).ConclusionsThe mean delay from symptom onset to GCA diagnosis was 9 weeks, or longer when cranial symptoms were absent. Our research provides an evidence-based benchmark for diagnostic delay of GCA and supports the need for improved public awareness and fast-track diagnostic pathways.Electronic supplementary materialThe online version of this article (doi:10.1186/s12916-017-0871-z) contains supplementary material, which is available to authorized users.

show abstract

Section: Resultsmentioning

confidence: 99%

Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis

Prior

Ranjbar

Belcher

et al. 2017

BMC Med

View full text Add to dashboard Cite

show abstract

“…Cette complication survenait dans 60% des cas avant l’ère des corticoïdes. La corticothérapie est le seul traitement ayant prouvé son efficacité [ 5 , 14 ], son effet spectaculaire est considéré comme un test diagnostic. Les corticoïdes d'action courte et de bonne biodisponibilité, dont le Prédnisone ou le Méthylprednisone, sont à privilégier.…”

Section: Discussionunclassified

Acouphènes révélateurs de la maladie de Horton

Ouraini¹,

Rouihi²,

Nakkabi³

et al. 2015

Pan Afr Med J

View full text Add to dashboard Cite

La maladie de Horton est une artérite giganto-cellulaire touchant les artères de gros et de moyen calibre du territoire céphalique. Elle a une expression clinico-biologique polymorphe. Le diagnostic de certitude est posé devant des formes typiques comportant des critères diagnostiques cliniques et paracliniques établis par l'ACR (American College of Rhumatology). Cependant certaines formes atypiques de la maladie peuvent faire retarder le diagnostic, c'est le cas notamment des formes révélées par des manifestations ORL qui sont inhabituelles et peu spécifiques. Le but de ce travail est de rapporter un cas atypique de la maladie de Horton révélé par des acouphènes, le retard diagnostique pouvant être à l'origine d'une mauvaise prise en charge thérapeutique, avec des risques de complications vasculaires graves.

show abstract